 The Companys Update on its Development of COVID-19 Drug Candidate is Promising Vancouver, British Columbia--Newsfile Corp. - March 31, 2020 - NanoViricides, Inc. NYSE American: NNVC the Company is a nano-biopharmaceutical Company at the development stage, with proprietary and patented drug development work focused on viral diseases. The Companys research involves the use of a unique nanomedicine technology called nanoviricides -- agents designed to fool a virus into attaching to an antiviral nanomachine, in ... 